THE PATHOPHYSIOLOGY AND SEVERITY OF SYMPTOMS IN IBS PATIENTS ARE NOT ASSOCIATED WITH MUCOSAL IMMUNE ACTIVITY AS DETERMINED BY FECAL CALPROTECTIN

(1) Sahlgrenska Academy at University of Gothenburg

(2) Danone research



This item was part of the Faecal calprotection as a diagnostic tool in IBS and IBD session at UEG Week 2013

This item can be cited as: United European Gastroenterology Journal; 2013: 1 (Supplement 1) A68

You may be interested in:

How does this translate into the clinic?
English, Presentation, Neurogastroenterology & Motility, 2018
THE PATHOPHYSIOLOGY AND SEVERITY OF SYMPTOMS IN IBS PATIENTS ARE NOT ASSOCIATED WITH MUCOSAL IMMUNE ACTIVITY AS DETERMINED BY FECAL CALPROTECTIN
English, Irritable Bowel Syndrome, Brain-gut and gut-brain axes, neuro-hormonal, neuralimmune and visceral sensitivity, Abstract, 2013
Irritable Bowel Syndrome (IBS)
English, Presentation, Hepatobiliary, Disease Mechanisms, IBD, Neurogastroenterology & Motility, Gut Microbiota, 2017

Categorisation:

  • Clinical Specialty
    • Brain-gut and gut-brain axes, neuro-hormonal, neuralimmune and visceral sensitivity
  • Disease
    • Irritable Bowel Syndrome
  • Format
    • Abstract
  • Language
    • English
  • Year
    • 2013